Progression-associated genes in astrocytoma identified by novel microarray gene expression data reanalysis

Methods Mol Biol. 2007;377:203-22. doi: 10.1007/978-1-59745-390-5_13.


Astrocytoma is graded as pilocytic (WHO grade I), diffuse (WHO grade II), anaplastic (WHO grade III), and glioblastoma multiforme (WHO grade IV). The progression from low- to high-grade astrocytoma is associated with distinct molecular changes that vary with patient age, yet the prognosis of high-grade tumors in children and adults is equally dismal. Whether specific gene expression changes are consistently associated with all high-grade astrocytomas, independent of patient age, is not known. To address this question, we reanalyzed the microarray datasets comprising astrocytomas from children and adults, respectively. We identified nine genes consistently dysregulated in high-grade tumors, using four novel tests for identifying differentially expressed genes. Four genes encoding ribosomal proteins (RPS2, RPS8, RPS18, RPL37A) were upregulated, and five genes (APOD, SORL1, SPOCK2, PRSS11, ID3) were downregulated in high-grade by all tests. Expression results were validated using a third astrocytoma dataset. APOD, the most differentially expressed gene, has been shown to inhibit tumor cell and vascular smooth muscle cell proliferation. This suggests that dysregulation of APOD may be critical for malignant astrocytoma formation, and thus a possible novel universal target for therapeutic intervention. Further investigation is needed to evaluate the role of APOD, as well as the other genes identified, in malignant astrocytoma development.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Adult
  • Astrocytoma / classification
  • Astrocytoma / genetics*
  • Biomarkers, Tumor / genetics*
  • Brain Neoplasms / classification
  • Brain Neoplasms / genetics*
  • Child
  • Chromosomes, Human
  • Cluster Analysis
  • Data Interpretation, Statistical
  • Disease Progression
  • Gene Expression Regulation, Neoplastic
  • Gene Expression*
  • Humans
  • Models, Genetic
  • Neoplasm Recurrence, Local
  • Oligonucleotide Array Sequence Analysis / methods*
  • Reproducibility of Results


  • Biomarkers, Tumor